Balanced news tone
News Sentiment
BHC sentiment intelligence
Bausch Health Companies Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
55 relevant articles
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-2.4% over one week, -5.5% over four weeks, trend inactive, and below fair value.
BHC4634780 Bond Profile — Key Metrics
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
78/100 classification
One-week reaction
-2.4%
Price reacting lower
Trend fit
Trend inactive
-5.5% over four weeks
Fair value
-31.5%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
7
Neutral
45
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
PR Newswire
Direct company coverage
Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 20:15
- Source
- PR Newswire
GlobeNewswire
Direct company coverage
Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 13:02
- Source
- GlobeNewswire
Stock Titan
Direct company coverage
Hear Bausch Health chiefs in live RBC healthcare chat May 20
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Stock Titan
The Motley Fool
Direct company coverage
Bausch Health (BHC) Q1 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Apr 2026 07:00
- Source
- The Motley Fool
Market source
Direct company coverage
Bausch Health (BHC) Lags Q1 Earnings Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Compared to Estimates, Bausch (BHC) Q1 Earnings: A Look at Key Metrics
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Bausch Health Companies Inc. (BHC): Billionaire Howard Marks Likes This Pharma Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- Market source
Investing.com
Direct company coverage
Bausch Health launches Biafine skincare emulsion online in U.S.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Investing.com
Market source
Direct company coverage
A Look Back at Health Insurance Providers Stocks’ Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Is the Options Market Predicting a Spike in Bausch Health Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Mar 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Bausch (BHC) Down 15.2% Since Last Earnings Report: Can It Rebound?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 20 Mar 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Potential Bausch + Lomb Separation Reframes Bausch Health
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Mar 2026 08:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts
- Tone
- Negative 34/100
- Event
- Balance sheet
- Published
- 01 Mar 2026 08:00
- Source
- simplywall.st
Market source
Direct company coverage
Should Bausch Health’s Profit Return and 2026 Outlook Shift the Investment Case for BHC?
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 27 Feb 2026 08:00
- Source
- Market source
simplywall.st
Direct company coverage
Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi‑Year Share Price Declines?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 27 Feb 2026 08:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
The Bull Case For Bausch Health (BHC) Could Change Following Mixed 2025 Results And 2026 Outlook Guidance
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 23 Feb 2026 08:00
- Source
- simplywall.st
Market source
Direct company coverage
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 23 Feb 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Feb 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Curious about Bausch (BHC) Q4 Performance? Explore Wall Street Estimates for Key Metrics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Feb 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Has The Market Gone Too Far In Marking Down Bausch Health (BHC) Shares?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Feb 2026 08:00
- Source
- Market source
The Motley Fool
Direct company coverage
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 10 Dec 2025 08:00
- Source
- The Motley Fool
PR Newswire
Direct company coverage
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 11 Sep 2025 07:00
- Source
- PR Newswire
simplywall.st
Direct company coverage
Improved Revenues Required Before Bausch Health Companies Inc. (NYSE:BHC) Stock's 30% Jump Looks Justified
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Aug 2025 07:00
- Source
- simplywall.st
PR Newswire
Direct company coverage
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 12 Aug 2025 07:00
- Source
- PR Newswire
PR Newswire
Direct company coverage
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jul 2025 07:00
- Source
- PR Newswire